Tag: Antimicrobial Resistance

Sales of veterinary antimicrobials in Europe decreased by about 20%

A new report published by European Medicines Agency (EMA) shows that the overall sales of veterinary antimicrobials across Europe have decreased by more than 20% between 2011 and 2016.

Boston Pharmaceuticals licenses three anti-infective programs from Novartis

antimicrobial resistance
Novartis has entered into a licensing and equity agreement with Boston Pharmaceuticals for the development of three novel anti-infective drug candidates.

GARDP and Novartis to cooperate on enhancing generic antibiotics

microbiology plates
The Global Antibiotic Research & Development Partnership (GARDP) and Novartis are joining forces to accelerate the development and availability of generic antibiotic treatments for children.

Genentech antibiotic displays high activity against superbugs

antibiotic resistance
Recently published findings demonstrate that optimized arylomycin analogues could translate into new therapies to address the growing threat of multidrug-resistant Gram-negative infections.

Natural blue clay minerals are effective against major bacterial infections

Researchers at Arizona State University and Mayo Clinic have found that at least one type of blue clay may help fight disease-causing bacteria in wounds, including antibiotic-resistant bacteria.

Bioengineers discovered promising antibiotic candidates

Researchers from The Massachusetts Institute of Technology and the University of Naples Federico II found that fragments of the protein pepsinogen can kill bacteria such as Salmonella and E. coli.

British scientists launched new open-access database called AntibioticDB

microbiology plates
The new resource is the result of a collaboration between the University of Birmingham, the John Innes Centre and the British Society for Antimicrobial Chemotherapy.

UK government launches AMR research competition

Antimicrobial resistance
The Department of Health and Social Care (UK) is announcing the launch of a £10 million (approximately €11,3 million) research competition to fund innovations to tackle antimicrobial resistance in humans.

Boston College researchers made a step towards targeted antibiotics

The approach of Boston College scientists maps, ranks, and identifies where antibiotic sensitivity functions reside in the genome of strains of S. pneumoniae.

Four UK universities received research grants to fight AMR

antimicrobial resistance
Multimillion grants have been awarded to four UK universities to conduct interdisciplinary research into the biological, social, cultural and economic drivers behind the development of antimicrobial resistance (AMR).

Evotec and Sanofi join forces to fight infectious diseases

microbiology plates
Evotec signed a transaction agreement with Sanofi to integrate Sanofi’s infectious disease unit into its organisation. Evotec will also licence-in the majority of Sanofi’s infectious disease research portfolio and initiatives.

A study on prevalence of antibiotic resistance was conducted in Russia

Antimicrobial resistance
GSK published the results of its Survey of Antibiotic Resistance in Russia. The collected data revealed high sensitivity of the main bacteria causing respiratory infections to amoxicillin/clavulanate and fluoroquinolones.

British scientists developed a novel alternative to antibiotics

antimicrobial resistance
A British nanotech company has created a potentially life changing technology that aims to overcome the global crisis of antibiotic resistance. Researchers from AGA Nanotech have developed a unique alternative to antibiotics.

Symcel starts collaboration with Karolinska Institutet

microbiology plates
Symcel, developer of the revolutionary cell-based assay tool for real-time cell metabolism measurements, partnered with the Karolinska Institutet in a Horizon 2020 funded project.

Scientists distinguished a new class of antibiotics

A team of researchers led by Brown University infectious disease experts and engineers has identified a new class of antibiotics that could one day help combat the alarming emergence of drug-resistant “superbugs.”

The Dutch regulator is alarmed by antibiotics problem

The Dutch regulator has raised concerns about a shortage of narrow-spectrum antibiotics. A lack of targeted therapies is forcing doctors to use broad-spectrum antibiotics that increase the risk of antimicrobial resistance.